ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) VERSUS CHEMOTHERAPY FOR THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN 2ND REMISSION (CR-2) - THE MSKCC EXPERIENCE

Authors
BOULAD F STEINHERZ P REYES B GILLIO A SMALL T KERNAN NA OREILLY RJ
Citation
F. Boulad et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) VERSUS CHEMOTHERAPY FOR THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN 2ND REMISSION (CR-2) - THE MSKCC EXPERIENCE, Blood, 84(10), 1994, pp. 10000251-10000251
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000251 - 10000251
Database
ISI
SICI code
0006-4971(1994)84:10<10000251:ABT(VC>2.0.ZU;2-Q